Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
Nathalie Conrad(University of Oxford), Geraldine Cambridge(University College London), Shivani Misra(Imperial College Healthcare NHS Trust), Geert Molenberghs(Transnational University Limburg), Jan Y. Verbakel(University of Oxford), Peter Taylor(Cardiff University), Iain B. McInnes(University of Glasgow), Naveed Sattar(University of Glasgow), Kamlesh Khunti(University of Leicester), Geert Verbeke(Hasselt University), Justin C Mason(Imperial College London), John J.V. McMurray(Western Infirmary)
Cited by 787
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k